osteoarthritis patient survey

Global Survey Will Help Us Understand Patient Perceptions

Globally, osteoarthritis (OA) is the third most rapidly rising condition associated with disability. We know the disease affects people of all ages, and given the current rate of population aging, it is estimated that the number of people who suffer from this disease will double in the next three decades. These are staggering statistics that we are actively trying to change.

Science holds the key to finding better treatments for everyone with arthritis. It’s essential we learn more about what’s important to patients from the patients themselves, so future healthcare options are most effective. We’ve partnered with other organizations in the Osteoarthritis Task Force to create the Global Osteoarthritis (OA) Patient Perception Survey (GOAPPS)– the first global survey of its kind to directly compare Quality of Life (QoL) in OA patients in the same survey across many languages and cultures. The goal of the survey is to help all stakeholders in OA healthcare develop a better understanding of patients’ perceptions and how they may differ between cultures. Understanding patients’ needs will help make OA-related healthcare options more effective in terms of prevention, research and management.

The GOAPPS survey project will collect and analyze data to address current gaps in understanding of OA patient perceptions and needs.  If you are an OA patient over the age of 18 and would like to participate, click here. The results will be published later this year.

GOAPPS is an initiative of the International Osteoarthritis Task Force. The Task Force is led by the OA Foundation International (OAFI) in Barcelona, Spain and the Arthritis Foundation in Atlanta, United States. The Task Force also includes members from the Pan-American League of Associations for Rheumatology (PANLAR) in North and South America and the Italian Association of Patients with Rheumatic Disease as well as additional global OA experts.

Related Resources:

Tags: , , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *